Since SF3B1 and PHF6 mutations can both serve as driver mutations and play key roles in the development of a variety of myeloid neoplasms, it is of clinical importance to clarify the issue of their potential mutual exclusivity. The gene discussed is SF3B1; the disease is myeloid neoplasm.